Home LiteratureArticle Details
PMID: 12433515 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children.

Lancet (London, England) ·Vol. 360 ·No. 9344 ·2002-11-09 ·Pages 1468-75

Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal AL, Granger DL, Anstey NM, Weinberg JB

Abstract

Nitric oxide (NO) is a mediator of immunity to malaria, and genetic polymorphisms in the promoter of the inducible NO synthase gene (NOS2) could modulate production of NO. We postulated that NOS2 promoter polymorphisms would affect resistance to severe malaria. We assessed genomic DNA from healthy children and from those diagnosed with malaria from Tanzania (n=47 and n=138, respectively) and Kenya (n=1106) for polymorphisms by single-stranded conformational polymorphism (SSCP) analysis and sequencing. We also measured in-vivo NO production in Tanzanian children. We identified a novel single nucleotide polymorphism, -1173 C-->T, in the NOS2 promoter that was significantly associated with protection from symptomatic malaria (odds ratio 0.12, 95% CI 0.03-0.48, p=0.0006) in 179 Tanzanian children, and significantly associated with protection from severe malarial anaemia (adjusted relative risk 0.25, 95% CI 0.09-0.66, p=0.0005) in 1106 Kenyan children studied over 5 years. The risk of parasitaemia was not significantly different in wild-type or -1173 C-->T individuals. -1173 C-->T protection in Tanzanians was independent of the previously recognised NOS2-954 G-->C polymorphism. The (CCTTT)(n) NOS2 polymorphism (Tanzania and Kenya) was not associated with severe malaria outcomes. -1173 C-->T was associated with increased fasting urine and plasma NO metabolite concentrations in Tanzanian children, suggesting that the polymorphism was functional in vivo. Interpretation The NOS2 promoter -1173 C-->T single nucleotide polymorphism is associated with protection against cerebral malaria and severe malarial anaemia. Increased NO production in individuals with the -1173 C-->T polymorphism lends support to a protective role for NO against these syndromes. Targeted interventions to increase NO delivery or production could provide novel preventive and therapeutic strategies against these major causes of mortality in African children.

MeSH Terms
Anemia/etiology,immunology Child Child, Preschool Female Humans Immunity, Innate/genetics Infant Kenya Malaria, Cerebral/immunology Malaria, Falciparum/complications,genetics,immunology,metabolism Male Nitric Oxide/biosynthesis Nitric Oxide Synthase/genetics Nitric Oxide Synthase Type II Parasitemia/immunology Polymorphism, Genetic Polymorphism, Single-Stranded Conformational Sequence Analysis, DNA Tanzania
Chemicals
Nitric Oxide NOS2 protein, human Nitric Oxide Synthase Nitric Oxide Synthase Type II
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Hobbs Maurine R
Department of Internal Medicine, University of Utah and VA Medical Centers, Salt Lake City, UT, USA.
Udhayakumar Venkatachalam
Levesque Marc C
Booth Jennifer
Roberts Jacquelin M
Tkachuk Ariana N
Pole Ann
Coon Hilary
Kariuki Simon
Nahlen Bernard L
Mwaikambo Esther D
Lal Altaf L
Granger Donald L
Anstey Nicholas M
Weinberg J Brice
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
2002-11-09
Pages
1468-75
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Grants
NIAID NIH HHS · R01 AI041764 · United States
NCI NIH HHS · 5P30CA42014 · United States
NIAID NIH HHS · AI41764 · United States
NCRR NIH HHS · M01-RR00064 · United States
Corrections
ErratumIn
-
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]